Valneva SE (VALN) EPS (Basic) (2021 - 2026)
Valneva SE's (VALN) quarterly EPS (Basic) came in at -$0.91 in Q1 2026, down 271.61% year-on-year from $0.53 in Q1 2025, and up 52.78% quarter-over-quarter from -$1.92 in Q4 2025.
Valneva SE (VALN) EPS (Basic) (2021 - 2026) Analysis & Trends
Valneva SE has disclosed EPS (Basic) across 6 years of filings, most recently posting -$0.91 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.91, down 271.61% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.7 (down 145.23% YoY), and the FY2025 annual result was -$0.79, down 825.92% from the prior year.
- EPS (Basic) came in at -$0.91 for Q1 2026 at Valneva SE, up from -$1.92 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $78480.4 in Q3 2022 to a low of -$104320.8 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.8 (2023), against an average of -$1520.9.
- Across the five-year window, EPS (Basic) jumped 508.78% in 2024 and slumped 1395.99% in 2025, its largest moves.
- Valneva SE's EPS (Basic) stood at -$0.41 in 2022, then surged by 55.97% to -$0.18 in 2023, then rose by 28.34% to -$0.13 in 2024, then plunged by 1395.99% to -$1.92 in 2025, then soared by 52.78% to -$0.91 in 2026.
- The last three EPS (Basic) figures came in at -$0.91 (Q1 2026), -$1.92 (Q4 2025), and -$1.44 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.06 |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | -0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.91 |
| Dec 31, 2025 | -1.92 |
| Sep 30, 2025 | -1.44 |
| Jun 30, 2025 | -0.43 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -0.51 |
| Jun 30, 2024 | -1.03 |
| Mar 31, 2024 | 3.26 |
| Dec 31, 2023 | -0.18 |
| Sep 30, 2023 | -1.07 |
| Jun 30, 2023 | -0.88 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -0.41 |
| Sep 30, 2022 | 78,480.43 |
| Jun 30, 2022 | -8.06 |
| Mar 31, 2022 | -104,320.83 |
| Dec 31, 2021 | 1.61 |
| Sep 30, 2021 | -62,779.68 |